emedastine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| antihistaminics | 999 | 87233-61-2 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
None
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| BA (Bioavailability) | 50 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Dec. 29, 1997 | FDA | ALCON |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | S01GX06 | SENSORY ORGANS OPHTHALMOLOGICALS DECONGESTANTS AND ANTIALLERGICS Other antiallergics |
| FDA MoA | N0000000190 | Histamine H1 Receptor Antagonists |
| FDA EPC | N0000175519 | Histamine-1 Receptor Inhibitor |
| CHEBI has role | CHEBI:37955 | H1 receptor antagonists |
| CHEBI has role | CHEBI:50857 | anti-allergic drugs |
| CHEBI has role | CHEBI:59683 | antipruritic drugs |
| MeSH PA | D018926 | Anti-Allergic Agents |
| MeSH PA | D018494 | Histamine Agents |
| MeSH PA | D006633 | Histamine Antagonists |
| MeSH PA | D006634 | Histamine H1 Antagonists |
| MeSH PA | D018377 | Neurotransmitter Agents |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Urticaria | indication | 126485001 | |
| Itching of skin | indication | 418363000 | |
| Allergic conjunctivitis | indication | 473460002 | DOID:11204 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 7.03 | Basic |
| pKa2 | 4.98 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Histamine H1 receptor | GPCR | ANTAGONIST | Ki | 8.89 | DRUG LABEL | DRUG LABEL |
External reference:
| ID | Source |
|---|---|
| D02249 | KEGG_DRUG |
| 87233-62-3 | SECONDARY_CAS_RN |
| 4021082 | VANDF |
| 4024099 | VANDF |
| C0064263 | UMLSCUI |
| CHEBI:4779 | CHEBI |
| CHEMBL594 | ChEMBL_ID |
| CHEMBL2103739 | ChEMBL_ID |
| DB01084 | DRUGBANK_ID |
| C043345 | MESH_SUPPLEMENTAL_RECORD_UI |
| 3219 | PUBCHEM_CID |
| 7174 | IUPHAR_LIGAND_ID |
| 6257 | INN_ID |
| 9J1H7Y9OJV | UNII |
| 216882 | RXNORM |
| 11537 | MMSL |
| 4654 | MMSL |
| 007385 | NDDF |
| 007386 | NDDF |
| 108846000 | SNOMEDCT_US |
| 108847009 | SNOMEDCT_US |
| 372551003 | SNOMEDCT_US |
Pharmaceutical products:
None